Get 20% lifetime commission for referring investors to digrin.com
here.
GT Biopharma, Inc. ( GTBP) - Key Metrics
GTBP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.12 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.09 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$4.18 | -$0.73 | -$0.73 |
| 2025Q3 | $0 | $2.11 | -$0.93 | -$0.93 |
| 2025Q2 | $0 | -$10.88 | -$1.09 | -$1.09 |
GTBP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.02 |
| 2026Q1 | 0% | -0.93 |
| 2025Q4 | -0.63% | -0.04 |
| 2025Q3 | 1.02% | 0.14 |
| 2025Q2 | 0% | -1.63 |
GTBP
Price: $7.03
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.21 USD
P/E Ratio: 0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 64789
Market Capitalization: 7.7 million